Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection
Y. Matsuoka,1 K. Iwasaki,2 Y. Miwa,2 K. Horimi,1 K. Uchida,2 T. Kobayashi.1
1Renal Transplant Surgery, Aichi Medical University, Nagakute City, Aichi, Japan
2Kidney Disease and Transplant Immunology, Aichi Medical University, Nagakute City, Aichi, Japan.
Meeting: 2018 American Transplant Congress
Abstract number: C90
Keywords: Calcineurin, Kidney transplantation, Pharmacokinetics, Viral therapy
Session Information
Session Name: Poster Session C: Kidney Immunosuppression: Novel Regimens and Drug Minimization
Session Type: Poster Session
Date: Monday, June 4, 2018
Session Time: 6:00pm-7:00pm
Presentation Time: 6:00pm-7:00pm
Location: Hall 4EF
Background
Infectious complications under immunosuppressive therapy are inevitable problems. Viral infection (include reactivation) occurs at a certain frequency even if immunosuppressive agents are totally adjusted by Pharmacokinetic Study. We focused our attention on CD8 T cell directly related to anti-viral response. In this study, PD analysis was performed on CD4 and CD8 T cells and the relevance to viral infection was examined.
Methods
PD analysis was conducted by CFSE-based T cell proliferation assay after separation of CD4 and CD8 T cells. The 50% inhibitory concentration (IC50) and the percentage of T cell proliferation values at the lower plateau (Bottom) were considered as a criterion of sensitivity to calcineurin inhibitor. Cut off levels of Bottom was 25%.
(1) Retrospective Study
Bottom and IC50 were calculated from the sigmoid curve in 9 kidney transplant recipients with viral infection and 10 without infection, which were retrospectively compared with clinical findings.
(2) Prospective Study
PD analysis-based immunosuppressive therapy was performed in 12 patients. In patients with low Bottom (=high sensitivity to CNI), CNI dose was reduced from the early postoperative day. Viral infection was examined up to 4 months after transplantation. For patients with high Bottom , the standard immunosuppressive regimen was used.
Results
(1) Analysis of CD4 T cells showed no significant trends in Bottom and IC 50 for viral infection. Regarding CD8 T cells, viral infection was significantly related to a low Bottom of TAC. (P=0.013)
(2) High sensitivity to both CSA and TAC was observed in 2 patients. CNI was reduced to once a day from day 10. Two patients showed high sensitivity to either CSA or TAC. One patient reduced the CNI dose on day 10, while the other was treated with a lower sensitivity drug at a standard dose. The remaining 8 patients with low sensitivity were given CNI at a standard dose. As a result of PD analysis based immunosuppression, the prevalence of viral infection was reduced (0/12, 0%), compared with conventional treatment (23/105, 21%).
Conclusions
Immunosuppressive therapy based on PD analysis targeting CD8 T cells was considered effective for preventing post-transplant viral infection. PD analysis can be used to improve the incompleteness of PK study, leading to implement of individualized immunosuppression.
CITATION INFORMATION: Matsuoka Y., Iwasaki K., Miwa Y., Horimi K., Uchida K., Kobayashi T. Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection Am J Transplant. 2017;17 (suppl 3).
To cite this abstract in AMA style:
Matsuoka Y, Iwasaki K, Miwa Y, Horimi K, Uchida K, Kobayashi T. Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection [abstract]. https://atcmeetingabstracts.com/abstract/once-daily-cni-administration-based-on-pharmacodynamic-analysis-for-preventing-viral-infection/. Accessed November 23, 2024.« Back to 2018 American Transplant Congress